Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

TMO

$665.61

Updated: 23/09/2026, 22:05:37

Market Cap
$246.11B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Stock valuation chart
One-year closing share-price history for TMO
Company Profile

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

USD
NYSE
CEO: Marc N. Casper
Employees: 125,000
https://www.thermofisher.com
Asset Summaries
Latest generated summaries for TMO

No summaries found.

Detailed business
The latest official filing is available; structured extraction is pending.
TMO-10-k-fy2025.html3.1 MBtext/htmlENFiled 26/02/2026Period ended 31/12/2025

The original document can be viewed now. Detailed facts and exposure relationships will appear after the separate extraction job completes.

Full company information
Latest profile, trading, valuation, and identifier data stored for TMO.
Share price
$665.61
Market cap
$246.11B
Exchange
NYSE
Currency
USD
CEO
Marc N. Casper
Employees
125,000
IPO date
17/03/1980
Beta
0.854
Last dividend
$0.00
Day range
$655.78 – $671.47
52-week range
$435.27 – $671.47
1-day performance
1.08%
1-year performance
52.92%
Current drawdown (1Y)
-0.87%
CIK
0000097745
CUSIP
883556102
ISIN
US8835561023
Created
07/12/2025, 14:35:39
Last update
23/09/2026, 22:05:37

Track Thermo Fisher Scientific Inc. with an AI analyst

See which prediction-market events move TMO, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to TMO from your Railway `news_articles` table.

Thermo Fisher Scientific Inc. (TMO) Analyst/Investor Day Transcript

Seeking Alpha • STOCK • 22/05/2026, 19:40:43

Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of Life-changing Therapies

Business Wire • STOCK • 28/04/2026, 10:30:00

Thermo Fisher to Sell Microbiology Business to Astorg

WSJ • STOCK • 27/04/2026, 11:09:00

Thermo Fisher to sell its microbiology business to Astorg for about $1.08 billion

Reuters • STOCK • 27/04/2026, 10:11:17

Thermo Fisher Scientific: Why A Slow Q1 Does Not Reflect The Growth Opportunities

Seeking Alpha • STOCK • 23/04/2026, 23:36:32

Thermo Fisher Scientific (NYSE: TMO) Q1 Earnings Review: Revenue Growth Amidst EPS Miss

Market Data • Market Data • 23/04/2026, 16:05:14

Thermo Fisher Scientific Inc. (TMO) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 23/04/2026, 13:31:37

Thermo Fisher (TMO) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research • STOCK • 23/04/2026, 12:32:12

Thermo Fisher Scientific (TMO) Q1 Earnings and Revenues Top Estimates

Zacks Investment Research • STOCK • 23/04/2026, 10:21:05

Thermo Fisher: Great Business Still Trading At A Risky Price Before Earnings

Seeking Alpha • STOCK • 20/04/2026, 13:01:45

Thermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy?

Zacks Investment Research • STOCK • 16/04/2026, 13:05:56

TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results?

Zacks Investment Research • STOCK • 16/04/2026, 12:20:18